Doctor profile · Federal record
Dr. REECE ALLAWATT, PMHNP-BC
Psychiatric/Mental Health Nurse Practitioner (CMS: NURSE PRACTITIONER) · LONGVIEW, WA
- NPI 1992192660
- Accepts Medicare
- 4 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1146 14TH AVE
LONGVIEW, WA 986323017
(877) 522-1275
fax (509) 491-3031 - Mailing address
-
500 SW 7TH ST STE A205
RENTON, WA 980572983
Credentials & registration
- NPI registered
- April 2015 — 11 yrs on file
- Profile last updated
- March 4, 2025
- Year of graduation
- 2022 — 4 yrs since
- Specialty taxonomy
- 363LP0808X — NUCC code
- State license (1)
- Washington #AP61300991
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1992192660. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
391
Distinct HCPCS
5
Medicare allowed
$35,800
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
80307 |
Testing for presence of drug, by chemistry analyzers | 143 | 23 | $61 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 100 | 20 | $108 | |
G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 78 | 16 | $112 | |
82075 |
Measurement of alcohol level in breath specimen | 37 | 14 | $29 | |
G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | 33 | 13 | $195 |
In context: peer comparison
Among 5 peers in this city , average services per provider: 80. This provider delivers 4.9× the peer median.Open Payments
Industry payments received
All-time total
$79
Transactions
3
Manufacturers
3
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Braeburn Inc. | 1 | $31.35 | |
| Indivior Inc. | 1 | $30.26 | |
| Alkermes, Inc. | 1 | $17.52 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
309
Patients
43
Total drug cost
$50,807
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl) | Brand | 209 | 31 | $31,308 |
| Suboxone (Buprenorphine Hcl/Naloxone Hcl) | Brand | 50 | 12 | $18,828 |
| Buprenorphine Hcl | Generic | 23 | 0 | $503 |
| Clonazepam | Generic | 16 | 0 | $124 |
| Mirtazapine | Generic | 11 | 0 | $43 |